NEW YORK — The HudsonAlpha Institute for Biotechnology said on Monday that one of its postdoctoral researchers has won a $118,335 grant from the National Institutes of Health to continue research into the genetics of Alzheimer's disease.
With the funding, Nicholas Cochran — a senior postdoc in the lab of HudsonAlpha's Richard Myers — aims to study the regulation of the gene that encodes tau, a protein that is abnormally hyperphosphorylated and aggregates in the brains of Alzheimer's disease patients, and how it is influenced by rare variants.